We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$132M
AUM Growth
-$14.8M
Cap. Flow
-$22.6M
Cap. Flow %
-17.18%
Top 10 Hldgs %
54.12%
Holding
159
New
33
Increased
15
Reduced
30
Closed
40

Top Buys

Rank Stock Value
1
LBRDK icon
Liberty Broadband Class C
LBRDK
+$3.61M
2
SI
Silvergate Capital Corporation
SI
+$3.17M
3
ACIA
Acacia Communications Inc
ACIA
+$2.94M
4
TSG
The Stars Group Inc.
TSG
+$2.01M
5
BABA icon
Alibaba
BABA
+$1.5M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$4.52M
2
FOX icon
Fox Class B
FOX
+$3.9M
3
RP
RealPage, Inc.
RP
+$3.8M
4
CELG
Celgene Corp
CELG
+$3.65M
5
AGN
Allergan plc
AGN
+$3.33M

Sector Composition

Rank Sector Weight
1 Technology 40.19%
2 Consumer Discretionary 14.17%
3 Healthcare 14.13%
4 Communication Services 6.47%
5 Financials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APPS icon
101
Digital Turbine
APPS
$1.76B
$73K 0.06%
10,300
-2,400
-19% -$17.8K
RIGL icon
102
Rigel Pharmaceuticals
RIGL
$762M
$72K 0.05%
3,380
– –
SACH
103
Sachem Capital Corp
SACH
$39.5M
$70K 0.05%
16,200
– –
ARAY icon
104
Accuray
ARAY
$34.9M
$69K 0.05%
24,400
-1,200
-5% -$3.33K
EGY icon
105
Vaalco Energy
EGY
$599M
$69K 0.05%
30,900
– –
PVLA
106
Palvella Therapeutics
PVLA
$2.22B
$68K 0.05%
234
+85
+57% +$23.6K
NPKI
107
NPK International
NPKI
$1.16B
$68K 0.05%
10,900
– –
BDSI
108
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$68K 0.05%
10,800
– –
CRBP icon
109
Corbus Pharmaceuticals
CRBP
$183M
$67K 0.05%
407
– –
MCHX icon
110
Marchex
MCHX
$79.7M
$67K 0.05%
17,700
– –
AGEN
111
Agenus
AGEN
$281M
$66K 0.05%
825
-235
-22% -$15.8K
HBIO icon
112
Harvard Bioscience
HBIO
$28M
$66K 0.05%
2,170
– –
OPCH icon
113
Option Care Health
OPCH
$3.65B
$66K 0.05%
4,450
– –
ITI
114
DELISTED
Iteris, Inc.
ITI
$66K 0.05%
13,200
– –
TCRT icon
115
Alaunos Therapeutics
TCRT
$4.79M
$65K 0.05%
91
– –
MNKD icon
116
MannKind Corp
MNKD
$1.3B
$63K 0.05%
48,600
– –
CPRX
117
DELISTED
Catalyst Pharmaceutical
CPRX
$59K 0.04%
+15,800
New +$73.9K
ENZ
118
DELISTED
Enzo Biochem, Inc.
ENZ
$51K 0.04%
19,500
– –
ATHX
119
DELISTED
Athersys, Inc. Common Stock
ATHX
$50K 0.04%
1,640
– –
AFG icon
120
American Financial Group
AFG
$12B
– –
-1,900
Closed -$205K
ASIX icon
121
AdvanSix
ASIX
$425M
– –
-27,257
Closed -$701K
ASRT
122
DELISTED
Assertio
ASRT
– –
-723
Closed -$56K
BAP icon
123
Credicorp
BAP
$30.6B
– –
-1,300
Closed -$271K
BBAR icon
124
BBVA Argentina
BBAR
$3.41B
– –
-32,400
Closed -$140K
BBY icon
125
Best Buy
BBY
$17.2B
– –
-3,800
Closed -$262K
3 4
5
6 7

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return

HighVista Strategies's Q4 2019 Portfolio in Review

As of Q4 2019, HighVista Strategies held 159 positions worth $132M, down 10% from $147M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

HighVista Strategies withdrew a net $22.6M in Q4 2019, closing 40 positions and reducing 30 holdings. Its most notable exit was Medicines Co, an estimated $4.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, HighVista Strategies opened a new position in Liberty Broadband Class C worth $3.9M.

  • HighVista Strategies's largest Q4 2019 buy was Liberty Broadband Class C: 31,000 shares worth $3.9M.
  • HighVista Strategies added most to Alibaba in Q4 2019, an estimated $1.5M increase.
  • HighVista Strategies's biggest Q4 2019 reduction was Allergan plc, cutting an estimated $3.33M.
  • HighVista Strategies fully exited Medicines Co in Q4 2019, selling an estimated $4.52M.
  • HighVista Strategies's ten largest holdings make up 54% of its $132M portfolio in Q4 2019.
  • HighVista Strategies opened 33 new positions and closed 40 in Q4 2019.
  • HighVista Strategies's portfolio value fell 10% quarter-over-quarter to $132M.

Based on HighVista Strategies's 13F filing for Q4 2019, filed 14 Feb 2020.